Notable Movers: Cree, Inc.(NASDAQ:CREE), Impax Laboratories Inc(NASDAQ:IPXL), Wireless Ronin Technologies, Radian Group Inc(NYSE:RDN)

Lakeway, NY -- (SBWIRE) -- 03/05/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Cree, Inc.(NASDAQ:CREE) shares climbed 10.73% to $49.50 in the early hour. The company today raised its adjusted earnings guidance for the third quarter to about $0.31 to $0.36 per share from the previous forecast ranging $0.30 to $0.35 per share.The company further raised its third quarter revenue to a range of $335 to $350 million from the previous estimate between $325 million and $345 million.
Additionally, CREE introduced a game-changing series of LED bulbs at a retail price point that gives consumers a reason to switch to LED lighting.

Get Latest News, Updates on CREE Here

Impax Laboratories Inc(NASDAQ:IPXL)shares declined 23.50% to $15.30 in the morning hour. The company yesterday reported that the FDA completed its re-inspection of the company's Hayward manufacturing facility in connection with the Form 483 issued in March last year. At the conclusion of the inspection, the FDA issued a new Form 483 with twelve observations, three of which are designated as repeat observations from the inspections.

Is IPXL a Strong Buying Opportunity After The Recent Slump? Find out Here

Wireless Ronin Technologies, Inc.(NASDAQ:RNIN) shares fell 19.78% to $2.15.The company reported that it has entered into agreements to sell approximately $1.56 million of its securities in a registered direct offering and the shares are being offered pursuant to a shelf registration statement filed with the Securities and Exchange Commission (SEC), w.e.f January 31, 2013.

Is RNIN Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

Radian Group Inc(NYSE:RDN) shares dropped 5.57% to $10.42 after the company yesterdayannounced that it has completed its previously announced concurrent public offerings of 39.1 million shares and have received aggregate net proceeds of approximately $299.5 million from Common Stock Offering and $389.8 million from the Convertible Notes Offering. The Company intends to use the proceeds from the offerings to fund working capital requirements.

Is RDN a Strong Buying Opportunity After The Recent Slump? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.